Notably, despite similar electrophysiological manifestations and responses to cholinesterase inhibitors, approximately 10% of MG patients are double negative for both anti-AChR antibodies and anti-MuSK antibodies as measured by standard RIPA, a condition termed seronegative MG (SNMG) (3). Here, BCHE is linked to myasthenia gravis.